Delayed
Japan Exchange
20:41:39 2024-05-27 EDT
|
5-day change
|
1st Jan Change
|
915
JPY
|
-0.33%
|
|
-1.72%
|
+12.82%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
7,167
|
6,020
|
6,569
|
5,423
|
8,104
|
Enterprise Value (EV)
1 |
4,683
|
5,917
|
4,795
|
5,449
|
8,108
|
P/E ratio
|
6.67
x
|
11.6
x
|
16.5
x
|
21.1
x
|
12.5
x
|
Yield
|
2.86%
|
3.78%
|
1.89%
|
3.19%
|
3.4%
|
Capitalization / Revenue
|
0.11
x
|
0.09
x
|
0.12
x
|
0.1
x
|
0.13
x
|
EV / Revenue
|
0.07
x
|
0.09
x
|
0.09
x
|
0.1
x
|
0.13
x
|
EV / EBITDA
|
3,314,492
x
|
6,150,348
x
|
29,240,674
x
|
11,281,217
x
|
8,350,222
x
|
EV / FCF
|
23,879,551
x
|
-3,012,927
x
|
3,259,453
x
|
-3,395,966
x
|
314,876,342
x
|
FCF Yield
|
0%
|
-0%
|
0%
|
-0%
|
0%
|
Price to Book
|
0.42
x
|
0.35
x
|
0.33
x
|
0.3
x
|
0.42
x
|
Nbr of stocks (in thousands)
|
10,254
|
10,343
|
10,346
|
10,174
|
10,207
|
Reference price
2 |
699.0
|
582.0
|
635.0
|
533.0
|
794.0
|
Announcement Date
|
19-06-20
|
20-06-24
|
21-06-23
|
22-06-21
|
23-06-21
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
63,750
|
64,671
|
64,508
|
54,621
|
56,945
|
64,329
|
EBITDA
|
-
|
1,413
|
962
|
164
|
483
|
971
|
EBIT
1 |
1,200
|
1,238
|
737
|
-74
|
231
|
692
|
Operating Margin
|
1.88%
|
1.91%
|
1.14%
|
-0.14%
|
0.41%
|
1.08%
|
Earnings before Tax (EBT)
1 |
1,315
|
1,442
|
854
|
665
|
444
|
979
|
Net income
1 |
823
|
957
|
521
|
398
|
261
|
650
|
Net margin
|
1.29%
|
1.48%
|
0.81%
|
0.73%
|
0.46%
|
1.01%
|
EPS
2 |
95.41
|
104.8
|
50.37
|
38.47
|
25.25
|
63.76
|
Free Cash Flow
|
-
|
196.1
|
-1,964
|
1,471
|
-1,604
|
25.75
|
FCF margin
|
-
|
0.3%
|
-3.04%
|
2.69%
|
-2.82%
|
0.04%
|
FCF Conversion (EBITDA)
|
-
|
13.88%
|
-
|
897.1%
|
-
|
2.65%
|
FCF Conversion (Net income)
|
-
|
20.49%
|
-
|
369.66%
|
-
|
3.96%
|
Dividend per Share
2 |
12.00
|
20.00
|
22.00
|
12.00
|
17.00
|
27.00
|
Announcement Date
|
18-11-08
|
19-06-20
|
20-06-24
|
21-06-23
|
22-06-21
|
23-06-21
|
Fiscal Period: March |
2020 S1
|
2021 S1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Net sales
1 |
31,970
|
24,685
|
27,110
|
13,926
|
13,956
|
29,292
|
16,526
|
16,604
|
33,285
|
20,027
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
393
|
-437
|
4
|
41
|
78
|
132
|
355
|
176
|
375
|
439
|
Operating Margin
|
1.23%
|
-1.77%
|
0.01%
|
0.29%
|
0.56%
|
0.45%
|
2.15%
|
1.06%
|
1.13%
|
2.19%
|
Earnings before Tax (EBT)
1 |
457
|
-269
|
145
|
119
|
199
|
326
|
424
|
280
|
516
|
531
|
Net income
1 |
310
|
-222
|
86
|
79
|
129
|
183
|
283
|
170
|
321
|
362
|
Net margin
|
0.97%
|
-0.9%
|
0.32%
|
0.57%
|
0.92%
|
0.62%
|
1.71%
|
1.02%
|
0.96%
|
1.81%
|
EPS
2 |
30.05
|
-21.50
|
8.310
|
7.640
|
12.73
|
17.98
|
27.79
|
16.67
|
31.44
|
35.49
|
Dividend per Share
|
10.00
|
-
|
5.000
|
-
|
-
|
7.000
|
-
|
-
|
10.00
|
-
|
Announcement Date
|
19-11-12
|
20-11-12
|
21-11-10
|
22-02-10
|
22-08-09
|
22-11-11
|
23-02-13
|
23-08-09
|
23-11-14
|
24-02-13
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
26
|
4
|
Net Cash position
1 |
1,293
|
2,484
|
103
|
1,774
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
0.0538
x
|
0.004119
x
|
Free Cash Flow
|
-
|
196
|
-1,964
|
1,471
|
-1,605
|
25.8
|
ROE (net income / shareholders' equity)
|
5.4%
|
5.68%
|
3.1%
|
2.1%
|
1.43%
|
3.57%
|
ROA (Net income/ Total Assets)
|
1.73%
|
1.72%
|
1.07%
|
-0.11%
|
0.33%
|
0.99%
|
Assets
1 |
47,567
|
55,698
|
48,778
|
-370,923
|
77,934
|
65,465
|
Book Value Per Share
2 |
1,887
|
1,680
|
1,664
|
1,941
|
1,765
|
1,878
|
Cash Flow per Share
2 |
697.0
|
673.0
|
433.0
|
586.0
|
434.0
|
427.0
|
Capex
|
-
|
175
|
347
|
364
|
400
|
339
|
Capex / Sales
|
-
|
0.27%
|
0.54%
|
0.67%
|
0.7%
|
0.53%
|
Announcement Date
|
18-11-08
|
19-06-20
|
20-06-24
|
21-06-23
|
22-06-21
|
23-06-21
|
|
1st Jan change
|
Capi.
|
---|
| +12.82% | 60.29M | | -35.08% | 1.44B | | +6.85% | 1.17B | | +0.37% | 974M | | -12.01% | 582M | | +43.52% | 575M | | +27.26% | 561M | | +9.61% | 268M | | -31.93% | 227M | | +5.05% | 219M |
Commodity Chemicals Wholesale
|